Table 1.
Exosome and exosomal cargo as biomarkers or therapeutics of HCC
Sample type | Exosome or exosomal cargo | Outcome | Reference | |
---|---|---|---|---|
HCC patients with LT | Serum | miR-718 | Biomarker for HCC recurrence and prognosis | [52] |
HCC/Hepattis B patients | Serum | miR-221, miR191, miR-181a and miR-26a | Biomarker for early-stage HCC diagnosis | [53] |
HCC rats | Serum | Exosome | Biomarker for early-stage HCC diagnosis | [54] |
HCC patients | Serum | miR-21 | Biomarker for HCC diagnosis | [55] |
HCC patients | Serum | miR-27b-3p, miR-92a-3p | Targets of HCC therapy | [56] |
HCC cell lines | Cell culture medium | Exosome | miRNA transfer and contribute to HCC metastases | [57] |